We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
131 hedge funds and large institutions have $987M invested in Esperion Therapeutics in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 13
52% more capital invested
Capital invested by funds: $647M → $987M (+$340M)
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
13.51% more ownership
Funds ownership: 81.22% → 94.73% (+14%)
10% more funds holding
Funds holding: 119 → 131 (+12)
24% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 51
71% less call options, than puts
Call options by funds: $29.9M | Put options by funds: $103M
Holders
131
Holders Change
+12
Holders Change %
+10.08%
% of All Funds
3.27%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.17%
New
26
Increased
39
Reduced
51
Closed
13
Calls
$29.9M
Puts
$103M
Net Calls
-$73.5M
Net Calls Change
-$27M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$40.2M |
| 2 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
+$21.5M |
| 3 |
MG
Meditor Group
Hamilton,
Bermuda
|
+$20.8M |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$11.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$10.5M |
Top Sellers
| 1 |
PP
PDT Partners
New York
|
-$11.1M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$10.1M |
| 3 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$6.62M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$5.44M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.09M |
